Literature DB >> 20815044

Trans-catheter closure of patent ductus arteriosus-What is the best device?

Abdolrahim Ghasemi1, Swati Pandya, Surendranath Veeram Reddy, Daniel R Turner, Wei Du, Mohamad Ali Navabi, Mohammad Reza Mirzaaghayan, Abdolrazagh Kiani, Katherine Sloan, Thomas J Forbes.   

Abstract

BACKGROUND: Over the past three decades, transcatheter occlusion of patent ductus arteriosus (PDA) has evolved to be the procedure of choice. Gianturco and Flipper coils are the most commonly used coils in the United States for closure of small and moderate size PDAs. For larger PDAs, interventionalists in the United States commonly use the Amplatzer Duct Occluder (ADO) and those in Europe use the ADO or the Nit-Occlud Coils (NOC). A comparison between Gianturco coils, Flipper coils, ADO, and NOC has never been made.
OBJECTIVE: To compare the success and complication rate associated with the four different devices used for transcatheter closure of PDA. Success was defined as complete closure of PDA with absence of a residual shunt (R.S.) at six months follow-up.
METHODS: Two institutions collaborated in combining their data to evaluate the results of transcatheter closure of PDA.
RESULTS: Totally, 546 patients underwent successful PDA occlusion at both institutions. Gianturco and Flipper coils were used in 120 (22%) and 119 (22%) patients respectively. A total of 152 (28%) patients received ADO and 155 (28%) patients received NOC. Immediate R.S. were noted in 226 (41.4%) patients in the entire study group with the NOC group having the highest percentage of R.S. (80/155, 51.6%, P = 0.004). Of the 484 patients with follow-up echocardiograms at 6 months, 35 (7.2%) patients had persistent R.S. The NOC (3/143, 2.1%) and ADO (5/150, 3.3%) groups had the least R.S. at six months follow-up.
CONCLUSION: Per our definition of success, the Nit-Occlud coils and the Amplatzer duct-occluder devices had significantly higher success rate for PDA occlusion versus the coils.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20815044     DOI: 10.1002/ccd.22393

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  19 in total

1.  Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg.

Authors:  Osman Baspinar; Ahmet Irdem; Ercan Sivasli; Derya Aydin Sahin; Metin Kilinc
Journal:  Pediatr Cardiol       Date:  2012-05-31       Impact factor: 1.655

2.  A fully biodegradable patent ductus arteriosus occlude.

Authors:  Ying Ying Huang; Yee Shan Wong; Jing Ni Chan; Subbu S Venkatraman
Journal:  J Mater Sci Mater Med       Date:  2015-02-04       Impact factor: 3.896

3.  Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.

Authors:  Meki Bilici; Fikri Demir; Alper Akın; Mehmet Türe; Hasan Balık; Mahir Kuyumcu
Journal:  Pediatr Cardiol       Date:  2017-08-21       Impact factor: 1.655

4.  Update on the Amplatzer duct occluder: a 10-year experience in Asia.

Authors:  Charles C Cuaso; Reina Bianca M Tan; Jonas D Del Rosario; Dexter D Cheng; Karl G Reyes
Journal:  Pediatr Cardiol       Date:  2011-11-22       Impact factor: 1.655

5.  Transcatheter closure of symptomatic arterial duct in infants younger than 1 year old.

Authors:  Biagio Castaldi; Giuseppe Santoro; Gianpiero Gaio; Maria Teresa Palladino; Carola Iacono; Maria Giovanna Russo
Journal:  Pediatr Cardiol       Date:  2012-05-26       Impact factor: 1.655

6.  Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate?

Authors:  Saktheeswaran Mahesh Kumar; Venkateshwaran Subramanian; Sasidharan Bijulal; Kavassery Mahadevan Krishnamoorthy; Sivasubramonian Sivasankaran; Jaganmohan A Tharakan
Journal:  Pediatr Cardiol       Date:  2013-04-17       Impact factor: 1.655

7.  Experience with percutaneous closure of ductus arteriosus using the Amplatzer duct occluder in 243 consecutive patients and long-term results-A single centre study.

Authors:  Mostafa Behjati-Ardakani; Mohammad Amin Behjati-Ardakani; Mehdi Hadadzadeh; Seyed Hossein Moshtaghion; Mohammadtaghi Sarebanhassanabadi
Journal:  Niger Med J       Date:  2014-09

8.  A Retrospective Study of 1,526 Cases of Transcatheter Occlusion of Patent Ductus Arteriosus.

Authors:  Mei Jin; Yong-Mei Liang; Xiao-Fang Wang; Bao-Jing Guo; Ke Zheng; Yan Gu; Zhen-Yu Lyu
Journal:  Chin Med J (Engl)       Date:  2015-09-05       Impact factor: 2.628

9.  Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience.

Authors:  Howaida G El-Said; Andras Bratincsak; Susan R Foerster; Joshua J Murphy; Julie Vincent; Ralf Holzer; Diego Porras; John Moore; Lisa Bergersen
Journal:  J Am Heart Assoc       Date:  2013-11-27       Impact factor: 5.501

Review 10.  What Interventional Cardiologists Are Still Leaving to the Surgeons?

Authors:  Worakan Promphan; Shakeel A Qureshi
Journal:  Front Pediatr       Date:  2016-06-13       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.